Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background and aim Previous studies showed that renal dysfunction was associated with both a reduction in serum high-density lipoprotein (HDL) cholesterol concentration and increased circulating monocyte count. We aimed to investigate the effect of circulating monocyte to serum HDL cholesterol ratio (M/H ratio) on fatal and composite cardiovascular events, in an observational cohort study of chronic kidney disease (CKD) patients.Materials and methods A total of 340 subjects with stage 1-5 CKD were followed for a mean follow-up period of 33 (range 2-44) months and assessed for fatal and nonfatal CV events. M/H ratio was calculated for all patients. All-cause mortality and CVE were also analyzed in relation to M/H ratio.Results Monocyte/HDL cholesterol ratio was negatively correlated with estimated glomerular filtration rate (eGFR) (r = -0.43, P < 0.001). Notably, both fatal and combined fatal and nonfatal cardiovascular events were more common in patients having a M/H ratio in the third tertile was associated with a hazard ratio of 2.24 and 4.91, respectively, for fatal and composite cardiovascular events compared to being in the first tertile.Conclusion Monocyte/HDL cholesterol ratio was increased with decreasing eGFR in predialytic CKD patients. Most importantly, we report for the first time that an increased M/H ratio was cross-sectionally associated with a worse cardiovascular profile and arose as independent predictors of major cardiovascular events during follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [26]
In the citing paper
“It was demonstrated that patients with hemodynamically significant stenosis (FFR ≤ 0.80) had higher MHR values, and through multivariate analysis, this ratio was found to be an independent predictor of low FFR values [26].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [26]
Citations
Cites
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 2×
“In the presence of excessive metabolic and oxidative stress (such as in uremia), HDL might lose its protective effect and may behave as a pro-inflammatory molecule [12].”
BackgroundK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.
(2003) · PubMed · Cited by 1,394
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890 · cited 1×
“Plaque macrophages account for the majority of leukocytes in plaques and are believed to be different from monocytes recruited from circulating blood [1].”
BackgroundAnsell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590 · cited 1×
“Inflammatory/anti-inflammatory properties of HDL also distinguish better patients that are favorably affected by simvastatin treatment [14].”
BackgroundAdhesion mechanisms regulating the migration of monocytes
Imhof, B. A., & Aurrand-Lions, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1375 · Cited by 584 · cited 1×
“Recruited monocytes facing fatty deposits undergo activation and accumulate as foam cells [2, 3].”
BackgroundHigh-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P. A., Remaley, A. T., Sviridov, D., & Chin-Dusting, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168690 · Cited by 508 · cited 1×
“[5] showed in an experimental study that HDL and its major protein component—apolipoprotein A–I (apo A–I)—exhibit an antiinflammatory effect on human monocytes by inhibiting activation of CD11b.”
BackgroundSpeer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310 · cited 1×
“[16] showed that symmetric dimethyl arginine (SDMA) could modify the HDL particle to mimic a damage-associated molecular pattern that activates toll-like receptor-2, linking abnormal HDL to innate immunity, endothelial dysfunction, and hypertension.”
BackgroundThe macrophage scavenger receptor at 30 years of age: current knowledge and future challenges
Greaves, D. R., & Gordon, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800066-jlr200 · Cited by 248 · cited 1×
“Recruited monocytes facing fatty deposits undergo activation and accumulate as foam cells [2, 3].”
BackgroundDysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
Yamamoto, S., Yancey, P. G., Ikizler, T. A., Jerome, W. G., Kaseda, R., Cox, B., Bian, A., Shintani, A., Fogo, A. B., Linton, M. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.013 · Cited by 199 · cited 2×
“[13] investigated the cellular cholesterol efflux and inflammatory response of macrophages exposed to HDL, in patients on hemodialysis treatment, compared to healthy controls.”
Background
Cited by
Items 201–284 of 284
Özkan, S., & Ecin, S. M. (2024) · Genel Tıp Dergisi · doi:10.54005/geneltip.1366271 · Cited by 2
A New Marker in Acute Ischemic Stroke Patients: Monocyte / HDL Ratio
Alagöz, A. N., Acar, B. A., Güngen, B. D., Aras, Y. G., & Acar, T. (2020) · Konuralp Tıp Dergisi · doi:10.18521/ktd.632555 · Cited by 2
Şanlıalp, S. Ç., Şanlıalp, M., Nar, G., & Yıldız, C. (2021) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/11238 · Cited by 1
Şirin, M. C., Arıdoğan, B. C., Çetin, E. S., Şirin, F. B., Temel, E. N., & Ünal, O. (2022) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-120764 · Cited by 1
“, it was noted that MHR could predict adverse clinical cardiovascular events in patients with chronic kidney disease (29).”
BackgroundOzmansur, E. N., Cansever, M., & Tahan, F. (2023) · Northern Clinics of Istanbul · doi:10.14744/nci.2022.92195 · Cited by 1
Sarı, A., Güngören, H., Kazan, E. D., Orhan, S., Duran, M., Sarı, S. A., & Bozkurt, E. (2023) · Health Sciences Quarterly · doi:10.26900/hsq.1886 · Cited by 1
Güzel, E., Mete, B., Kuleci, S., Saygıdeğer, Y., & Baydar, O. (2023) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1315487 · Cited by 1
Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients
Sedigh, H., Separham, A., Aslanabadi, N., Javan-ajdadi, R., & Mehravani, K. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.3126 · Cited by 1
“They reported an association between increased MHR and the presence of cardiovascular comorbidities in chronic kidney disease patients [31].”
BackgroundResearch Progress on Pathogenesis and Early Biomarkers of Diabetic Kidney Disease
王, 玉. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441079 · Cited by 1
Özcan, L., Polat, E. C., Baran, C., Boylu, A., Çulha, M. G., Erkoç, M., Danış, E., Bozkurt, M., & Ötünçtemur, A. (2024) · The French Journal of Urology · doi:10.1016/j.fjurol.2024.102670 · Cited by 1
Ragheb, C. S., Masry, M. R. E., Elbasel, M., Galal, M. A., & Rabiee, A. (2024) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-024-00379-5 · Cited by 1
“Kanbay et al. [15] �rst reported that MHR could predict cardiovascular events in patients with chronic kidney disease.”
Wang, T., Zhang, Y., Fang, C., & Xu, J. (2025) · Vascular · doi:10.1177/17085381251339242 · Cited by 2
Liu, H., Gan, F., Fu, K., Liu, L., Wang, T., Yang, H., & Fan, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1609798 · Cited by 1
Moriya, H., Hisada, R., Fujieda, Y., Kono, M., Amengual, O., Kato, M., Okada, K., Ito, Y. M., & Atsumi, T. (2025) · Rheumatology · doi:10.1093/rheumatology/keaf655 · Cited by 1
Günegül, N. E., Örenay, Ö. M., & Karaosmanoğlu, N. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04478-3 · Cited by 1
“MHR is widely used today, particularly in assessing risk factors for cardiovascular diseases [43, 44].”
Çalışkan, Z., Çaklılı, Ö. T., Yılmaz, Y., & Çalışkan, M. (2019) · Medeniyet Medical Journal · doi:10.5222/mmj.2019.85226 · Cited by 1
“After all inclusion and exclusion criteria were applied 40 patients with FMF [21 female, median age: 37 (27-47) age] and 35 controls [21 females, median age: 38 (35-40)] were recruited from -blin-”
MethodMonocyte to HDL-Cholesterol Ratio in Male with Hypogonadotropic Hypogonadism
Çadırcı, K., Oğuz, İ. S., Usta, T., Keskin, H., Çarlıoğlu, A., & Durmaz, Ş. A. (2019) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · Cited by 2
EL-SHALL, M. B. B. C. S. F. B. A. I., & EL-SOKKARY, M. D. A. F. A. H. F. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.53360 · Cited by 1
Çiçek, M. Ç., Günseren, K. Ö., AYDIN, Y. M., Yıldız, A., Elgin, E., & Ersoy, A. (2021) · Experimental and Clinical Transplantation · doi:10.6002/ect.2021.0024 · Cited by 1
Serın, S. O., Şişik, A., & Başak, F. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0244 · Cited by 1
李, 宁. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.126843 · Cited by 1
Monocyte to HDL Ratio in Preeclamptic Patients: Can It Be a Predictive Marker?
Köpük, Ş. Y., NACİ, N., Özcan, C., & İpek, U. L. U. (2022) · Clinical and Experimental Health Sciences · doi:10.33808/clinexphealthsci.1094774 · Cited by 1
Şaşkın, H. (2023) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2022-055 · Cited by 1
“reported in their study that high MHR was associated with worse cardiovascular profile in predialytic chronic renal failure patients with decreased estimated glomerular filtration rate (eGFR) and that MHR was an independent predictor of major cardiovascular events during follow up.(12) Again, Canpolat et al.”
Resultde Figueiredo, E. T., & Miranda, C. H. (2022) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2022e12410 · Cited by 1
Akkoç, M. F., Bülbüloğlu, S., Kapı, E., Bayram, M., & Gurgah, T. (2023) · Wound Repair and Regeneration · doi:10.1111/wrr.13070 · Cited by 1
“This suggests that the monocyte/ HDL ratio may be a predictor for determining the prognosis in the presence of inflammation.(25,26) In this study, it was aimed to investigate the monocyte/HDL ratio as a prognostic criterion in adult burn patients.”
BackgroundGhanem, I., Tantawy, A., & Shaker, A. (2023) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2023.294353 · Cited by 1
Tuncer, Z., Akbulut, N., Ekmekçi, U. C., Çirkinoğlu, G. G., Öztürk, V., & Erkin, Y. (2023) · Journal of Surgery and Medicine · doi:10.28982/josam.7884 · Cited by 1
Lao, Y., Li, X., Zhou, W., Zhu, H., Jiang, Y., Li, S., Jin, M. Y., & Wang, J. (2023) · Medicine · doi:10.1097/md.0000000000035454 · Cited by 2
“[32,33] Therefore, we speculated that the increase in MHR was related to the inflammatory response and injury of the liver and bile ducts in patients with PBC. APPR is a novel noninvasive inflammatory parameter.”
BackgroundUtlu, Z., Şebin, S. Ö., & Metin, N. (2023) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1348381 · Cited by 1
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
Julve, J., & Escolá‐Gil, J. C. (2022) · Biomedicines · doi:10.3390/biomedicines10030620 · Cited by 1
“The use of oxidized HDL (oxHDL) as a candidate biomarker for CVD was also assessed in another review published in this Special Issue [17].”
BackgroundInfluentialCirculating cells as biomarkers in cardiovascular disease : the difference between men and women
Zweers, T. J. (2015) · Leiden Repository (Leiden University)
Kaya, H. (2019) · Adıyaman Üniversitesi Sağlık Bilimleri Dergisi · doi:10.30569/adiyamansaglik.486890
“A recent study showed that MHR was negatively correlated with cardiovascular mortality in patients with chronic kidney disease (8).”
BackgroundKan, S., & Karaibrahimoğlu, A. (2019) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.640760
“Previously, Kanbay et al. reported that MHR was an independent marker for cardiovascular events in patients with chronic renal disease and was elevated in accordance with decrease in GFR (24).”
BackgroundMonocyte to HDL ratio as an indicator of subclinical atherosclerosis in diabetic retinopathy
Kan, S., & Karaibrahimoğlu, A. (2019) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.640710
“(2) reported that in chronic renal disease patients, MHR behaved like an independent marker for cardiovascular events.”
BackgroundCardiovascular Dısease Risk in Patients with Obstructıve Sleep Apnea Syndrome
Ölmez, H., & Işık, N. A. (2019) · Galician Medical Journal · doi:10.21802/gmj.2019.4.4
Evaluation of the Ratio of Monocyte / HDL Cholesterol in Psoriasis Patients
Namdar, N. D., Arıkan, İ., Kıdır, M., Koçak, F. E., Tak, H., & Sarici, G. (2020) · International Journal of Scientific and Technological Research · doi:10.7176/jstr/6-03-22
Kılıç, A., & Baydar, O. (2020) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.699728
Karabay, E. A., Demіr, D., & Çerman, A. A. (2020) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abdp.2019.05.002
Karaaslan, Ö. Ç., Ekizler, F. A., Özilhan, M. O., Çöteli, C., Ünal, S., & Maden, O. (2021) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2020.42243 · Cited by 1
Karahan, S., & Okuyan, E. (2021) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20776
“reported that MHR acts as an independent predictor for cardiovascular events and increases in parallel with the decrease in estimated glomerular filtration rate in patients with chronic kidney disease [12].”
Backgroundde Figueiredo, E. T. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-06122021-142908
Imig, J. D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734749853.793554746
Research Progress of MHR and Atherosclerosis in Chronic Obstructive Pulmonary Disease
王, 茵. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125691
Research Progress of AIP, MHR, hs-cTnI of Coronary Artery Disease
王, 蕾. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1281110
Birgani, Y. T., Ariafar, M., Akiash, N., & Sardabi, E. H. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns7.13400
“Kanbay and colleagues first reported a monocyte-to-HDL ratio as an independent prognostic marker for cardiovascular events in chronic kidney disease (32).”
BackgroundLaksmi, N. M. D., Gunadhi, I. G. N. P., Wirawan, H., & Maliawan, R. P. I. (2020) · Intisari Sains Medis · doi:10.15562/ism.v11i3.800
Li, Z., & Zhang, R. (2023) · Research Square · doi:10.21203/rs.3.rs-2497701/v1
Can Monocyte/HDL Ratio Be Used in the Follow-Up of Patients with Acromegaly?
Gülümsek, E., Aslan, M. Z., & Acıbucu, F. (2021) · JEURMEDS · doi:10.5578/jeurmeds.20210402
Monocytes and High-density Lipoprotein Cholesterol in Branch Retinal Vein Occlusion
Park, B. C., Cha, Y. W., & Kim, S. T. (2023) · Journal of Retina · doi:10.21561/jor.2023.8.1.30
Chen, X. F., Fan, E., Zhang, X., Jieensihan, A., Wang, S., Guo, N., Zhao, H., Abuduaini, Y., & Wang, H. (2023) · doi:10.22541/au.168963387.75502925/v1
Han, R., Li, J., Liu, Y., & Wang, W. (2023) · Research Square · doi:10.21203/rs.3.rs-3350347/v1
Üntan, İ., & Doğan, A. E. (2023) · Androloji Bülteni · doi:10.24898/tandro.2023.64935 · Cited by 1
Ergün, G., & Demirelli, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206440
“In addition, its prognostic importance has been shown in different studies [21,22].”
BackgroundPan, Y., Qian, S., & Xu, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3498743/v1
王, 玉. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112496
何, 健. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.144989
Wei, R., & Huang, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4209750/v1
杨, 宏. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1461754
Research Progress on MHR and Cardiovascular Complications of Chronic Kidney Disease
康, 雨. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1482357
Prognostic Value of Monocyte-to-High-Density Lipoprotein Cholesterol Ratio in COVID-19 Patients
Kılıt, C., Kilit, T. P., & Erarslan, S. (2024) · Journal of Contemporary Medicine · doi:10.16899/jcm.1549415
Meng, H., Zhou, X., Li, L., Liu, Y., Liu, Y., & Zhang, Y. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s502386
Research Progress of Blood Routine Derived Inflammatory Markers in Cardiovascular Diseases
祝, 逸. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541083
The association between monocyte/HDL-C ratio and heart failure
Çattık, B. N., Aksoy, N., Berk, B., & Güngör, B. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1694236
Deng, F., Sun, J., Liu, L., Zhang, M., Wang, X., Zhan, C., Qiu, C., Hu, J., & Xia, L. (2025) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257294388250326034612
Pei, J., Zaid, M., Wu, Y., Wang, N., Liu, X., Zhao, Q., Jiang, Y., Xu, W., & Zhao, G. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091516
“22 23 30–33 In this study, we explored the associations of monocyte count and MHR with the risk of CHD in Chinese populations based on a prospective cohort study, and established predictive models and risk scoring systems of CHD using the two biomarkers for their low cost to measure and…”
Aathira, V. S., & Ganguly, S. (2025) · Cureus · doi:10.7759/cureus.93737
“Kanbay et al., in a cohort study done on chronic kidney disease patients, suggested that high MHR is a bad prognostic factor for cardiovascular events in patients with chronic kidney disease [15].”
Association between pulmonary function tests and lipid levels
Akpınar, K., & Özkaya, A. L. (2025) · Medicine · doi:10.1097/md.0000000000045111
“[15,28,29] 30] Endothelial dysfunction is a precursor to atherosclerosis and is strongly associated with the progression of cardiovascular and microvascular complications.”
Chang, H., Wang, H., Wang, A., Sun, D., Zhao, Z., Ma, D., Lv, H., Wang, S., Guo, J., & Wang, F. (2025) · The Aging Male · doi:10.1080/13685538.2025.2598718 · Cited by 1
“However, HDL-C counteracts the proinflammatory and pro-oxidative effects of monocytes [20].”
Nam, K.-W., Kwon, H.-M., Jeong, H.-Y., Park, J.-H., & Min, K. (2024) · Figshare · doi:10.6084/m9.figshare.24946415
Wu, D., Chen, G., Lan, Y., Chen, S., Ding, X., Wei, C., Balmer, L. A., Wang, W., Wu, S., & Xu, W. (2024) · Figshare · doi:10.6084/m9.figshare.25101097
Lin, J., Li, Z., Xu, J., Pan, M., Yin, T., Wang, J., Sun, Q., Zheng, W., & Chen, R. (2024) · Figshare · doi:10.6084/m9.figshare.25893755
Hu, Y., Zheng, J., Xing, Y., Song, Y., & Wu, X. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s518916
Kashul, S. V., & Хухліна, О. С. (2025) · Medicni perspektivi · doi:10.26641/2307-0404.2025.4.348757
Monocyte to High-Density Lipoprotein Cholesterol Ratio Could be a Predictor of Dialysis Adequacy?
Biricik, M., & Yılmaz, Ü. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02271-5
Meng, X., Wen, Y., Wang, X., Yang, X., & Gao, L. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1620841
“First proposed by Kanbay et al. in 2014, MHR has been found to be associated with adverse cardiovascular events in patients with chronic kidney disease (12).”
Sönmezoğlu, H. İ., Sönmezoğlu, B. G., & Çakır, B. K. (2026) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2026.2626680
“Some studies suggest that MHR may more accurately reflect inflammatory status than traditional markers [18].”
Luo, S., Ma, K., Liu, T., Dong, J., Zhu, L., Shen, S., Kolberg, B., Li, J., Shi, J., & Zhang, J. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02914-5
“Increased levels of MHR have been shown to be associated with poor prognosis in patients experiencing ST-segment elevation myocardial infarction (STEMI) and to indicate heightened cardiovascular risk in individuals with chronic kidney disease [17, 18].”
Zainab, Z., Siregar, J., Hamdi, T., Siregar, D. I. S., Lubis, Z., & Loesnihari, R. (2026) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v32i2.2473
Li, D., Dong, J., Zhang, Z., Yang, X., & Zhang, J. (2026) · Science Progress · doi:10.1177/00368504261473732
“10 Similarly, Cetin et al. demonstrated that MHR was associated with cardiovascular mortality in stable coronary artery disease patients, 12 while Açıkgöz et al. observed comparable associations in patients undergoing percutaneous coronary intervention (HR = 2.0, 95% CI: 1.2-4.1).”
InfluentialKüçükukur, M., & Ekmekçi, C. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13090420
“That the group difference in MHR was driven by the monocyte numerator rather than by HDL (Table 1) mirrors the mechanistic framing under which the ratio was originally proposed [15,16].”
Hani, D. A. B., Alshraideh, J. A., Yousef, A. S., Alwahadneh, A. A., Alenazi, M. M., Alkhawaldeh, J. M., Alduraidi, H., Al-Nabulsi, S., & Al‐Zaiti, S. S. (2026) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2026.100943
“Likewise, Kanbay et al. identified MHR as an independent predictor of cardio-vascular events in patients with chronic kidney disease [21].”
Wang, J., Wang, Y., Li, L., Zhang, C., Wen, K., 皮晓红, Yao, K., & Du, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1946659
Subhashini, D., Dr Sajeetha Kumari, R., & Dr. Poorna Pragathi, B. (2026) · Adolescencia e Saude · doi:10.67440/ahj.vi.3113
Metadata
- Authors
- Kanbay, M., Solak, Y., Unal, H. U., Kurt, Y. G., Gok, M., Cetinkaya, H., Karaman, M., Oguz, Y., Eyileten, T., Vural, A., Covic, A., Goldsmith, D., Turak, O., & Yilmaz, M. I.
- Affiliations
- Istanbul Medeniyet University (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Spitalul Clinic Dr. C. I. Parhon (RO)
- St Thomas' Hospital (GB)
- Türkiye Yüksek İhtisas Hastanesi (TR)
- Corresponding author
- Kanbay, Mehmet
- Venue
- International Urology and Nephrology
- Published
- 2014-05-23
- Volume
- 46
- Issue
- 8
- Pages
- 1619-1625
- ISSN
- 0301-1623 (ISSN-L)
- 1573-2584
- OpenAlex
- W2035731392
- Cited by
- 276
- References
- 17
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 32 · 2023: 34 · 2022: 30 · 2021: 34 · 2020: 31 · 2019: 27 · 2018: 18 · 2017: 13 · 2016: 17 · 2015: 6
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Urology and Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- monocyte count, HDL cholesterol, chronic kidney disease, cardiovascular events, all-cause mortality, estimated glomerular filtration rate, cardiovascular risk prediction
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Leukocyte Count, Cholesterol, HDL, Male, Middle Aged, Monocytes, Myocardial Infarction, Prospective Studies, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.